Please assess the completion status of the following clinical trial:

Trial Title: Single-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Pediatric Subjects

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy Japanese aged 6 months to 19 years~Exclusion Criteria:~* History of anaphylaxis, serious vaccine reactions, hypersensitivity to vaccine viral proteins or excipients~* Administration of adjuvanted influenza vaccine or suspected influenza disease within 3 month prior to study start~* Administration of any other vaccines within 4 weeks prior to enrollment expect for seasonal influenza vaccines within 1 week~* History of progressive or severe neurological disorders

- Gender: ALL
- Minimum Age: 6 Months
- Maximum Age: 19 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: EXPERIMENTAL): Dose ranging
- 2 (Type: EXPERIMENTAL): Dose ranging

Based on this trial design, predict the completion outcome and termination type (if applicable).